{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:52:37Z","timestamp":1791381157737,"version":"4.3.3"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"DOI":"10.1038\/s41579-026-01373-0","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:54:51Z","timestamp":1791374091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting resistance evolution to guide antibiotic development"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5187-9903","authenticated-orcid":false,"given":"Csaba","family":"P\u00e1l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Szili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-5438","authenticated-orcid":false,"given":"Szilvia","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1373_CR1","unstructured":"World Health Organization. Analysis of Antibacterial Agents in Clinical and Preclinical Development: Overview and Analysis 2025 https:\/\/www.who.int\/publications\/i\/item\/9789240113091 (WHO, 2025)."},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jac\/dky019","volume":"73","author":"N Jackson","year":"2018","unstructured":"Jackson, N., Czaplewski, L. & Piddock, L. J. V. Discovery and development of new antibacterial drugs: learning from experience? J. Antimicrob. Chemother. 73, 1452\u20131459 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"1373_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","volume":"18","author":"U Theuretzbacher","year":"2020","unstructured":"Theuretzbacher, U., Outterson, K., Engel, A. & Karl\u00e9n, A. The global preclinical antibacterial pipeline. Nat. Rev. Microbiol. 18, 275\u2013285 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cmi.2023.09.024","volume":"31","author":"U Theuretzbacher","year":"2025","unstructured":"Theuretzbacher, U. Evaluating the innovative potential of the global antibacterial pipeline. Clin. Microbiol. Infect. 31, 903\u2013909 (2025).","journal-title":"Clin. Microbiol. Infect."},{"key":"1373_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","volume":"181","author":"K Lewis","year":"2020","unstructured":"Lewis, K. The science of antibiotic discovery. Cell 181, 29\u201345 (2020).","journal-title":"Cell"},{"key":"1373_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/420937","volume":"38","author":"B Spellberg","year":"2004","unstructured":"Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G. & Edwards, J. E. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38, 1279\u20131286 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"1373_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bcp.2016.10.005","volume":"133","author":"\u00c7 Y\u0131lmaz","year":"2017","unstructured":"Y\u0131lmaz, \u00c7. & \u00d6zcengiz, G. Antibiotics: pharmacokinetics, toxicity, resistance and multidrug efflux pumps. Biochem. Pharmacol. 133, 43\u201362 (2017).","journal-title":"Biochem. Pharmacol."},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/1040841X.2024.2313024","volume":"50","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal, R. et al. Antibiotic resistance: a global crisis, problems and solutions. Crit. Rev. Microbiol. 50, 896\u2013921 (2024).","journal-title":"Crit. Rev. Microbiol."},{"key":"1373_CR10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","volume":"257","author":"HC Neu","year":"1992","unstructured":"Neu, H. C. The crisis in antibiotic resistance. Science 257, 1064\u20131073 (1992).","journal-title":"Science"},{"key":"1373_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nrmicro1796","volume":"5","author":"JL Mart\u00ednez","year":"2007","unstructured":"Mart\u00ednez, J. L., Baquero, F. & Andersson, D. I. Predicting antibiotic resistance. Nat. Rev. Microbiol. 5, 958\u2013965 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tim.2017.11.005","volume":"26","author":"G Bell","year":"2018","unstructured":"Bell, G. & MacLean, C. The search for \u2018evolution-proof\u2019 antibiotics. Trends Microbiol. 26, 471\u2013483 (2018).","journal-title":"Trends Microbiol."},{"key":"1373_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrmicro.2017.75","volume":"15","author":"MOA Sommer","year":"2017","unstructured":"Sommer, M. O. A., Munck, C., Toft-Kehler, R. V. & Andersson, D. I. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15, 689\u2013696 (2017). This perspective piece advocates for a paradigm shift in preclinical antibiotic development, proposing the integration of experimental evolution and genomic analysis to proactively predict and mitigate resistance liabilities.","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR14","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/jac\/dky208","volume":"73","author":"LJ Farrell","year":"2018","unstructured":"Farrell, L. J. et al. Revitalizing the drug pipeline: antibioticDB, an open access database to aid antibacterial research and development. J. Antimicrob. Chemother. 73, 2284\u20132297 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"1373_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02580-12","author":"EJC Goldstein","year":"2013","unstructured":"Goldstein, E. J. C., Citron, D. M., Tyrrell, K. L. & Merriam, C. V. Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.02580-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1128\/AAC.03774-14","volume":"59","author":"K O\u2019Dwyer","year":"2015","unstructured":"O\u2019Dwyer, K. et al. Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. Antimicrob. Agents Chemother. 59, 289\u2013298 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.08.025","author":"BJ Werth","year":"2020","unstructured":"Werth, B. J. et al. Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.08.025 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"1373_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/cid\/ciac341","volume":"75","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Emergence of dalbavancin, vancomycin, and daptomycin nonsusceptible Staphylococcus aureus in a patient treated with dalbavancin: case report and isolate characterization. Clin. Infect. Dis. 75, 1641\u20131644 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1373_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","volume":"18","author":"C \u00c5rdal","year":"2020","unstructured":"\u00c5rdal, C. et al. Antibiotic development \u2014 economic, regulatory and societal challenges. Nat. Rev. Microbiol. 18, 267\u2013274 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-018-0135-0","volume":"11","author":"C \u00c5rdal","year":"2018","unstructured":"\u00c5rdal, C. et al. Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations. J. Pharm. Policy Pract. 11, 8 (2018).","journal-title":"J. Pharm. Policy Pract."},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41564-024-01891-8","volume":"10","author":"L Daruka","year":"2025","unstructured":"Daruka, L. et al. ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. Nat. Microbiol. 10, 313\u2013331 (2025). This study demonstrates that ESKAPE pathogens can rapidly evolve resistance to novel antibiotics when subjected to laboratory evolution, highlighting the importance of early evolutionary profiling.","journal-title":"Nat. Microbiol."},{"key":"1373_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl2103","volume":"17","author":"A Martins","year":"2025","unstructured":"Martins, A. et al. Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance. Sci. Transl. Med. 17, eadl2103 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"1373_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41564-023-01320-2","volume":"8","author":"G Apjok","year":"2023","unstructured":"Apjok, G. et al. Characterization of antibiotic resistomes by reprogrammed bacteriophage-enabled functional metagenomics in clinical strains. Nat. Microbiol. 8, 410\u2013423 (2023). The authors present a phage-based delivery system for functional metagenomics libraries that enables the direct screening and characterization of resistance genes within the native environment of clinical pathogens.","journal-title":"Nat. Microbiol."},{"key":"1373_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17735-y","volume":"11","author":"A Papkou","year":"2020","unstructured":"Papkou, A., Hedge, J., Kapel, N., Young, B. & MacLean, R. C. Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates. Nat. Commun. 11, 3970 (2020). This study shows that increased efflux pump activity speeds up the evolution of high-level resistance in S. aureus, thereby proving that the evolution of resistance is dependent of genomic context.","journal-title":"Nat. Commun."},{"key":"1373_CR26","doi-asserted-by":"publisher","first-page":"e00083-21","DOI":"10.1128\/msystems.00083-21","volume":"6","author":"S Dunn","year":"2021","unstructured":"Dunn, S., Carrilero, L., Brockhurst, M. & McNally, A. Limited and strain-specific transcriptional and growth responses to acquisition of a multidrug resistance plasmid in genetically diverse Escherichia coli lineages. mSystems 6, e00083-21 (2021).","journal-title":"mSystems"},{"key":"1373_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39416-2","volume":"14","author":"J Diaz Caballero","year":"2023","unstructured":"Diaz Caballero, J. et al. Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients. Nat. Commun. 14, 4083 (2023).","journal-title":"Nat. Commun."},{"key":"1373_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41579-023-00993-0","volume":"22","author":"CR MacNair","year":"2024","unstructured":"MacNair, C. R., Rutherford, S. T. & Tan, M.-W. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat. Rev. Microbiol. 22, 262\u2013275 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s44259-024-00047-2","volume":"2","author":"B Bogn\u00e1r","year":"2024","unstructured":"Bogn\u00e1r, B., Spohn, R. & L\u00e1z\u00e1r, V. Drug combinations targeting antibiotic resistance. npj Antimicrob. Resist. 2, 29 (2024).","journal-title":"npj Antimicrob. Resist."},{"key":"1373_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-micro-090816-093813","volume":"71","author":"D Hughes","year":"2017","unstructured":"Hughes, D. & Andersson, D. I. Evolutionary trajectories to antibiotic resistance. Annu. Rev. Microbiol. 71, 579\u2013596 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"1373_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41579-024-01041-1","volume":"22","author":"MJ Shepherd","year":"2024","unstructured":"Shepherd, M. J. et al. Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance. Nat. Rev. Microbiol. 22, 650\u2013665 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1126\/science.1120800","volume":"311","author":"VM D\u2019Costa","year":"2006","unstructured":"D\u2019Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 311, 374\u2013377 (2006).","journal-title":"Science"},{"key":"1373_CR33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1220761","volume":"337","author":"KJ Forsberg","year":"2012","unstructured":"Forsberg, K. J. et al. The shared antibiotic resistome of soil bacteria and human pathogens. Science 337, 1107\u20131111 (2012).","journal-title":"Science"},{"key":"1373_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature17672","volume":"533","author":"EC Pehrsson","year":"2016","unstructured":"Pehrsson, E. C. et al. Interconnected microbiomes and resistomes in low-income human habitats. Nature 533, 212\u2013216 (2016).","journal-title":"Nature"},{"key":"1373_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fmicb.2013.00138","volume":"4","author":"JA Perry","year":"2013","unstructured":"Perry, J. A. & Wright, G. D. The antibiotic resistance \u2018mobilome\u2019: searching for the link between environment and clinic. Front. Microbiol. 4, 138 (2013).","journal-title":"Front. Microbiol."},{"key":"1373_CR36","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature08187","volume":"460","author":"HH Wang","year":"2009","unstructured":"Wang, H. H. et al. Programming cells by multiplex genome engineering and accelerated evolution. Nature 460, 894\u2013898 (2009). This foundational paper introduces multiplex automated genome engineering (MAGE), a technology that enables the simultaneous modification of multiple genomic sites, thereby accelerating laboratory evolution and phenotypic optimization.","journal-title":"Nature"},{"key":"1373_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41586-018-0384-8","volume":"560","author":"SO Halperin","year":"2018","unstructured":"Halperin, S. O. et al. CRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window. Nature 560, 248\u2013252 (2018).","journal-title":"Nature"},{"key":"1373_CR38","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.cell.2018.10.021","volume":"175","author":"A Ravikumar","year":"2018","unstructured":"Ravikumar, A., Arzumanyan, G. A., Obadi, M. K. A., Javanpour, A. A. & Liu, C. C. Scalable, continuous evolution of genes at mutation rates above genomic error thresholds. Cell 175, 1946\u20131957 (2018).","journal-title":"Cell"},{"key":"1373_CR39","doi-asserted-by":"publisher","first-page":"E5726","DOI":"10.1073\/pnas.1801646115","volume":"115","author":"\u00c1 Nyerges","year":"2018","unstructured":"Nyerges, \u00c1. et al. Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance. Proc. Natl Acad. Sci. USA 115, E5726\u2013E5735 (2018). The authors demonstrate that directed evolution targeting multiple genomic loci simultaneously can predict complex, clinically relevant resistance trajectories that are missed by traditional single-step selection.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-023-00902-5","volume":"21","author":"F Sanz-Garc\u00eda","year":"2023","unstructured":"Sanz-Garc\u00eda, F. et al. Translating eco-evolutionary biology into therapy to tackle antibiotic resistance. Nat. Rev. Microbiol. 21, 671\u2013685 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR41","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41559-020-1235-1","volume":"4","author":"L Le\u00f3nidas Cardoso","year":"2020","unstructured":"Le\u00f3nidas Cardoso, L., Dur\u00e3o, P., Amicone, M. & Gordo, I. Dysbiosis individualizes the fitness effect of antibiotic resistance in the mammalian gut. Nat. Ecol. Evol. 4, 1268\u20131278 (2020). This study highlights the ecological context of antimicrobial resistance and shows that gut dysbiosis alters the competitive landscape, making the fitness cost of antibiotic resistance highly variable and dependent on the environment.","journal-title":"Nat. Ecol. Evol."},{"key":"1373_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03595-23","volume":"12","author":"Z Gestels","year":"2024","unstructured":"Gestels, Z. et al. Could traces of fluoroquinolones in food induce ciprofloxacin resistance in Escherichia coli and Klebsiella pneumoniae? An in vivo study in Galleria mellonella with important implications for maximum residue limits in food. Microbiol. Spectr. 12, e0359523 (2024).","journal-title":"Microbiol. Spectr."},{"key":"1373_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59019-3","volume":"16","author":"C Zhu","year":"2025","unstructured":"Zhu, C. et al. Global diversity and distribution of antibiotic resistance genes in human wastewater treatment systems. Nat. Commun. 16, 4006 (2025). This large-scale metagenomic analysis maps the global distribution of antibiotic resistance genes in wastewater treatment systems and identifies these systems as critical reservoirs for the environmental dissemination of these genes.","journal-title":"Nat. Commun."},{"key":"1373_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"DI Andersson","year":"2010","unstructured":"Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260\u2013271 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR45","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1021\/acsinfecdis.3c00156","volume":"9","author":"FR Chowdhury","year":"2023","unstructured":"Chowdhury, F. R. & Findlay, B. L. Fitness costs of antibiotic resistance impede the evolution of resistance to other antibiotics. ACS Infect. Dis. 9, 1834\u20131845 (2023).","journal-title":"ACS Infect. Dis."},{"key":"1373_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002299","volume":"13","author":"G Chevereau","year":"2015","unstructured":"Chevereau, G. et al. Quantifying the determinants of evolutionary dynamics leading to drug resistance. PLoS Biol. 13, e1002299 (2015).","journal-title":"PLoS Biol."},{"key":"1373_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003582","volume":"9","author":"D Skurnik","year":"2013","unstructured":"Skurnik, D. et al. A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries. PLoS Pathog. 9, e1003582 (2013).","journal-title":"PLoS Pathog."},{"key":"1373_CR48","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jir845","volume":"205","author":"JK Rudkin","year":"2012","unstructured":"Rudkin, J. K. et al. Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system. J. Infect. Dis. 205, 798\u2013806 (2012).","journal-title":"J. Infect. Dis."},{"key":"1373_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","volume":"28","author":"SE Luria","year":"1943","unstructured":"Luria, S. E. & Delbr\u00fcck, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491\u2013511 (1943).","journal-title":"Genetics"},{"key":"1373_CR50","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","volume":"44","author":"JL Martinez","year":"2000","unstructured":"Martinez, J. L. & Baquero, F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44, 1771\u20131777 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16932-z","volume":"11","author":"M Luka\u010di\u0161inov\u00e1","year":"2020","unstructured":"Luka\u010di\u0161inov\u00e1, M., Fernando, B. & Bollenbach, T. Highly parallel lab evolution reveals that epistasis can curb the evolution of antibiotic resistance. Nat. Commun. 11, 3105 (2020).","journal-title":"Nat. Commun."},{"key":"1373_CR52","doi-asserted-by":"publisher","first-page":"eadw9178","DOI":"10.1126\/sciadv.adw9178","volume":"11","author":"KJ Romanowicz","year":"2025","unstructured":"Romanowicz, K. J., Resnick, C., Hinton, S. R. & Plesa, C. Exploring antibiotic resistance in diverse homologs of the dihydrofolate reductase protein family through broad mutational scanning. Sci. Adv. 11, eadw9178 (2025).","journal-title":"Sci. Adv."},{"key":"1373_CR53","doi-asserted-by":"publisher","first-page":"128386","DOI":"10.1016\/j.micres.2025.128386","volume":"303","author":"Z Ling","year":"2026","unstructured":"Ling, Z. et al. mgrB inactivation confers enhanced pathogenicity and immune evasion over mcr-1 expression in colistin-resistant Klebsiella pneumoniae. Microbiol. Res. 303, 128386 (2026).","journal-title":"Microbiol. Res."},{"key":"1373_CR54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.84395","volume":"12","author":"Jangir","year":"2023","unstructured":"Jangir, et al. The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence. eLife 12, e84395 (2023).","journal-title":"eLife"},{"key":"1373_CR55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.tim.2018.01.005","volume":"26","author":"P Dur\u00e3o","year":"2018","unstructured":"Dur\u00e3o, P., Balbont\u00edn, R. & Gordo, I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 26, 677\u2013691 (2018).","journal-title":"Trends Microbiol."},{"key":"1373_CR56","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/genetics\/154.3.985","volume":"154","author":"BR Levin","year":"2000","unstructured":"Levin, B. R., Perrot, V. & Walker, N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154, 985\u2013997 (2000).","journal-title":"Genetics"},{"key":"1373_CR57","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1128\/AAC.01460-09","volume":"54","author":"P Schulz zur Wiesch","year":"2010","unstructured":"Schulz zur Wiesch, P., Engelst\u00e4dter, J. & Bonhoeffer, S. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob. Agents Chemother. 54, 2085\u20132095 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47088","volume":"8","author":"A Dunai","year":"2019","unstructured":"Dunai, A. et al. Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion. eLife 8, e47088 (2019).","journal-title":"eLife"},{"key":"1373_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5352","volume":"5","author":"V L\u00e1z\u00e1r","year":"2014","unstructured":"L\u00e1z\u00e1r, V. et al. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 5, 4352 (2014).","journal-title":"Nat. Commun."},{"key":"1373_CR60","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym, M., Stone, L. K. & Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351, aad3292 (2016).","journal-title":"Science"},{"key":"1373_CR61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","volume":"23","author":"C P\u00e1l","year":"2015","unstructured":"P\u00e1l, C., Papp, B. & L\u00e1z\u00e1r, V. Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol. 23, 401\u2013407 (2015).","journal-title":"Trends Microbiol."},{"key":"1373_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41576-023-00649-y","volume":"25","author":"SP Djordjevic","year":"2024","unstructured":"Djordjevic, S. P. et al. Genomic surveillance for antimicrobial resistance \u2014 a One Health perspective. Nat. Rev. Genet. 25, 142\u2013157 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"1373_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25096-3","volume":"12","author":"A-N Zhang","year":"2021","unstructured":"Zhang, A.-N. et al. An omics-based framework for assessing the health risk of antimicrobial resistance genes. Nat. Commun. 12, 4765 (2021).","journal-title":"Nat. Commun."},{"key":"1373_CR64","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41586-024-07530-w","volume":"632","author":"K Lewis","year":"2024","unstructured":"Lewis, K. et al. Sophisticated natural products as antibiotics. Nature 632, 39\u201349 (2024).","journal-title":"Nature"},{"key":"1373_CR65","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.tips.2014.10.007","volume":"35","author":"E Oldfield","year":"2014","unstructured":"Oldfield, E. & Feng, X. Resistance-resistant antibiotics. Trends Pharmacol. Sci. 35, 664\u2013674 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"1373_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2202","volume":"6","author":"LL Silver","year":"2007","unstructured":"Silver, L. L. Multi-targeting by monotherapeutic antibacterials. Nat. Rev. Drug Discov. 6, 41\u201355 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1373_CR67","doi-asserted-by":"publisher","first-page":"e00207-19","DOI":"10.1128\/AAC.00207-19","volume":"63","author":"P Szili","year":"2019","unstructured":"Szili, P. et al. Rapid evolution of reduced susceptibility against a balanced dual-targeting antibiotic through stepping-stone mutations. Antimicrob. Agents Chemother. 63, e00207-19 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s43856-024-00591-y","volume":"4","author":"A Dulanto Chiang","year":"2024","unstructured":"Dulanto Chiang, A. & Dekker, J. P. Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant Gram-negative bacteria. Commun. Med. 4, 170 (2024).","journal-title":"Commun. Med."},{"key":"1373_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41579-025-01247-x","volume":"24","author":"C Ntallis","year":"2026","unstructured":"Ntallis, C., Martin, N. I., Edwards, A. M. & Weingarth, M. Bacterial cell envelope-targeting antibiotics. Nat. Rev. Microbiol. 24, 183\u2013196 https:\/\/doi.org\/10.1038\/s41579-025-01247-x (2026).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","volume":"625","author":"C Zampaloni","year":"2024","unstructured":"Zampaloni, C. et al. A novel antibiotic class targeting the lipopolysaccharide transporter. Nature 625, 566\u2013571 (2024).","journal-title":"Nature"},{"key":"1373_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-023-06799-7","volume":"625","author":"KS Pahil","year":"2024","unstructured":"Pahil, K. S. et al. A new antibiotic traps lipopolysaccharide in its intermembrane transporter. Nature 625, 572\u2013577 (2024).","journal-title":"Nature"},{"key":"1373_CR72","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.bpj.2011.10.047","volume":"101","author":"Z Jia","year":"2011","unstructured":"Jia, Z., O\u2019Mara, M. L., Zuegg, J., Cooper, M. A. & Mark, A. E. The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II. Biophys. J. 101, 2684\u20132692 (2011).","journal-title":"Biophys. J."},{"key":"1373_CR73","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1086\/520283","volume":"26","author":"RC Moellering Jr.","year":"1998","unstructured":"Moellering, R. C. Jr. Vancomycin-resistant Enterococci. Clin. Infect. Dis. 26, 1196\u20131199 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"1373_CR74","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1128\/AAC.44.9.2276-2285.2000","volume":"44","author":"L Cui","year":"2000","unstructured":"Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H. & Hiramatsu, K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44, 2276\u20132285 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR75","first-page":"Doc46","volume":"19","author":"SS Adeiza","year":"2024","unstructured":"Adeiza, S. S. Clovibactin and Staphylococcus aureus: a new weapon against resistant strains. GMS Hyg. Infect. Control 19, Doc46 (2024).","journal-title":"GMS Hyg. Infect. Control"},{"key":"1373_CR76","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1021\/acs.joc.4c01414","volume":"89","author":"JEH Brunicardi","year":"2024","unstructured":"Brunicardi, J. E. H. et al. Structure\u2013activity relationship studies of the peptide antibiotic clovibactin. J. Org. Chem. 89, 12479\u201312484 (2024).","journal-title":"J. Org. Chem."},{"key":"1373_CR77","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.cell.2023.07.038","volume":"186","author":"R Shukla","year":"2023","unstructured":"Shukla, R. et al. An antibiotic from an uncultured bacterium binds to an immutable target. Cell 186, 4059\u20134073 (2023). This paper reports the discovery of a new class of antibiotics from uncultured bacteria, clovibactin, that binds an immutable cell-wall target, lLipid II, rendering the evolution of resistance exceptionally difficult.","journal-title":"Cell"},{"key":"1373_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56934-3","volume":"16","author":"E Maharramov","year":"2025","unstructured":"Maharramov, E. et al. Exploring the principles behind antibiotics with limited resistance. Nat. Commun. 16, 1842 (2025).","journal-title":"Nat. Commun."},{"key":"1373_CR79","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.cell.2020.05.005","volume":"181","author":"JK Martin","year":"2020","unstructured":"Martin, J. K. et al. A dual-mechanism antibiotic kills Gram-negative bacteria and avoids drug resistance. Cell 181, 1518\u20131532 (2020).","journal-title":"Cell"},{"key":"1373_CR80","doi-asserted-by":"publisher","first-page":"262ra156","DOI":"10.1126\/scitranslmed.3009940","volume":"6","author":"C Munck","year":"2014","unstructured":"Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H. & Sommer, M. O. A. Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci. Transl. Med. 6, 262ra156 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1373_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jbiosc.2015.02.003","volume":"120","author":"S Suzuki","year":"2015","unstructured":"Suzuki, S., Horinouchi, T. & Furusawa, C. Suppression of antibiotic resistance acquisition by combined use of antibiotics. J. Biosci. Bioeng. 120, 467\u2013469 (2015).","journal-title":"J. Biosci. Bioeng."},{"key":"1373_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau5480","volume":"368","author":"BP Lazzaro","year":"2020","unstructured":"Lazzaro, B. P., Zasloff, M. & Rolff, J. Antimicrobial peptides: application informed by evolution. Science 368, eaau5480 (2020).","journal-title":"Science"},{"key":"1373_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12364-6","volume":"10","author":"R Spohn","year":"2019","unstructured":"Spohn, R. et al. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance. Nat. Commun. 10, 4538 (2019). Through systematic evolutionary analysis, this study identifies specific antimicrobial peptides that induce minimal resistance, providing a blueprint for the design of evolutionarily stable therapeutics.","journal-title":"Nat. Commun."},{"key":"1373_CR84","doi-asserted-by":"publisher","first-page":"1026.e1","DOI":"10.1016\/j.cmi.2022.02.043","volume":"28","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 28, 1026.e1\u20131026.e5 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1373_CR85","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41429-025-00822-x","volume":"78","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Novel bifunctional antibacterial peptides mediated by a covalent conjugation strategy combat priority multidrug-resistant Gram-negative pathogens through dual targets. J. Antibiot. 78, 359\u2013369 (2025).","journal-title":"J. Antibiot."},{"key":"1373_CR86","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","volume":"5","author":"L Imamovic","year":"2013","unstructured":"Imamovic, L. & Sommer, M. O. A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5, 204ra132 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1373_CR87","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/msb.2013.57","volume":"9","author":"V L\u00e1z\u00e1r","year":"2013","unstructured":"L\u00e1z\u00e1r, V. et al. Bacterial evolution of antibiotic hypersensitivity. Mol. Syst. Biol. 9, 700 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"1373_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L. & Lindquist, S. Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol. 11, e1001692 (2013).","journal-title":"PLoS Biol."},{"key":"1373_CR89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","volume":"576","author":"Y Imai","year":"2019","unstructured":"Imai, Y. et al. A new antibiotic selectively kills Gram-negative pathogens. Nature 576, 459\u2013464 (2019).","journal-title":"Nature"},{"key":"1373_CR90","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10682-019-10027-y","volume":"34","author":"L Clarke","year":"2020","unstructured":"Clarke, L., Pelin, A., Phan, M. & Wong, A. The effect of environmental heterogeneity on the fitness of antibiotic resistance mutations in Escherichia coli. Evol. Ecol. 34, 379\u2013390 (2020).","journal-title":"Evol. Ecol."},{"key":"1373_CR91","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ng.2848","volume":"46","author":"TD Lieberman","year":"2014","unstructured":"Lieberman, T. D. et al. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat. Genet. 46, 82\u201387 (2014).","journal-title":"Nat. Genet."},{"key":"1373_CR92","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.aag0822","volume":"353","author":"M Baym","year":"2016","unstructured":"Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147\u20131151 (2016).","journal-title":"Science"},{"key":"1373_CR93","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1126\/science.287.5457.1479","volume":"287","author":"J Bj\u00f6rkman","year":"2000","unstructured":"Bj\u00f6rkman, J., Nagaev, I., Berg, O. G., Hughes, D. & Andersson, D. I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287, 1479\u20131482 (2000).","journal-title":"Science"},{"key":"1373_CR94","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/eva.12202","volume":"8","author":"T Vogwill","year":"2015","unstructured":"Vogwill, T. & MacLean, R. C. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol. Appl. 8, 284\u2013295 (2015).","journal-title":"Evol. Appl."},{"key":"1373_CR95","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cmi.2015.05.012","volume":"21","author":"DI Andersson","year":"2015","unstructured":"Andersson, D. I. Improving predictions of the risk of resistance development against new and old antibiotics. Clin. Microbiol. Infect. 21, 894\u2013898 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1373_CR96","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmi.2015.06.019","volume":"21","author":"U Theuretzbacher","year":"2015","unstructured":"Theuretzbacher, U. & Paul, M. Revival of old antibiotics: structuring the re-development process to optimize usage. Clin. Microbiol. Infect. 21, 878\u2013880 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1373_CR97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016886118","volume":"118","author":"KJ Card","year":"2021","unstructured":"Card, K. J., Thomas, M. D., Graves, J. L., Barrick, J. E. & Lenski, R. E. Genomic evolution of antibiotic resistance is contingent on genetic background following a long-term experiment with Escherichia coli. Proc. Natl Acad. Sci. USA 118, e2016886118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR98","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/516375","volume":"26","author":"DL Horn","year":"1998","unstructured":"Horn, D. L. et al. Why have group a Streptococci remained susceptible to penicillin? Report on a symposium. Clin. Infect. Dis. 26, 1341\u20131345 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"1373_CR99","doi-asserted-by":"publisher","first-page":"1117160","DOI":"10.3389\/fcimb.2023.1117160","volume":"13","author":"D Yu","year":"2023","unstructured":"Yu, D., Guo, D., Zheng, Y. & Yang, Y. A review of penicillin binding protein and group A Streptococcus with reduced-\u03b2-lactam susceptibility. Front. Cell. Infect. Microbiol. 13, 1117160 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1373_CR100","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02162-15","volume":"7","author":"N Stoesser","year":"2016","unstructured":"Stoesser, N. et al. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 7, e02162 (2016).","journal-title":"mBio"},{"key":"1373_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11571-5","volume":"10","author":"BM Forde","year":"2019","unstructured":"Forde, B. M. et al. Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection. Nat. Commun. 10, 3643 (2019).","journal-title":"Nat. Commun."},{"key":"1373_CR102","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1368-7646(03)00041-4","volume":"6","author":"I Chopra","year":"2003","unstructured":"Chopra, I., O\u2019Neill, A. J. & Miller, K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Updat. 6, 137\u2013145 (2003).","journal-title":"Drug Resist. Updat."},{"key":"1373_CR103","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41559-018-0547-x","volume":"2","author":"D Gifford","year":"2018","unstructured":"Gifford, D. et al. Identifying and exploiting genes that potentiate the evolution of antibiotic resistance. Nat. Ecol. Evol. 2, 1033\u20131039 (2018).","journal-title":"Nat. Ecol. Evol."},{"key":"1373_CR104","doi-asserted-by":"publisher","first-page":"msae086","DOI":"10.1093\/molbev\/msae086","volume":"41","author":"A Hinz","year":"2024","unstructured":"Hinz, A., Amado, A., Kassen, R., Bank, C. & Wong, A. Unpredictability of the fitness effects of antimicrobial resistance mutations across environments in Escherichia coli. Mol. Biol. Evol. 41, msae086 (2024).","journal-title":"Mol. Biol. Evol."},{"key":"1373_CR105","doi-asserted-by":"publisher","first-page":"e02303-17","DOI":"10.1128\/mBio.02303-17","volume":"9","author":"MMC Buckner","year":"2018","unstructured":"Buckner, M. M. C. et al. Clinically relevant plasmid-host interactions indicate that transcriptional and not genomic modifications ameliorate fitness costs of Klebsiella pneumoniae carbapenemase-carrying plasmids. mBio 9, e02303-17 (2018).","journal-title":"mBio"},{"key":"1373_CR106","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00713-22","volume":"8","author":"l Carrilero","year":"2023","unstructured":"Carrilero, l., Dunn, S. J., Moran, R. A., Mcnally, A. & Brockhurst, M. A. Evolutionary responses to acquiring a multidrug resistance plasmid are dominated by metabolic functions across diverse Escherichia coli lineages. mSystems 8, e0071322 (2023).","journal-title":"mSystems"},{"key":"1373_CR107","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67310","volume":"10","author":"P Ma","year":"2021","unstructured":"Ma, P. et al. Genetic determinants facilitating the evolution of resistance to carbapenem antibiotics. eLife 10, e67310 (2021).","journal-title":"eLife"},{"key":"1373_CR108","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/molbev\/msz109","volume":"36","author":"G Apjok","year":"2019","unstructured":"Apjok, G. et al. Limited evolutionary conservation of the phenotypic effects of antibiotic resistance mutations. Mol. Biol. Evol. 36, 1601\u20131611 (2019).","journal-title":"Mol. Biol. Evol."},{"key":"1373_CR109","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78834","volume":"11","author":"PK Jangir","year":"2022","unstructured":"Jangir, P. K. et al. Pre-existing chromosomal polymorphisms in pathogenic E. coli potentiate the evolution of resistance to a last-resort antibiotic. eLife 11, e78834 (2022).","journal-title":"eLife"},{"key":"1373_CR110","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","volume":"112","author":"TP Van Boeckel","year":"2015","unstructured":"Van Boeckel, T. P. et al. Global trends in antimicrobial use in food animals. Proc. Natl Acad. Sci. USA 112, 5649\u20135654 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56425-5","volume":"16","author":"KS Blake","year":"2025","unstructured":"Blake, K. S. et al. The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. Nat. Commun. 16, 1452 (2025).","journal-title":"Nat. Commun."},{"key":"1373_CR112","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.engmic.2024.100165","volume":"4","author":"W Su","year":"2024","unstructured":"Su, W. et al. Mechanisms of tigecycline resistance in Gram-negative bacteria: a narrative review. Eng. Microbiol. 4, 100165 (2024).","journal-title":"Eng. Microbiol."},{"key":"1373_CR113","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11783-019-1129-0","volume":"13","author":"CC Nguyen","year":"2019","unstructured":"Nguyen, C. C., Hugie, C. N., Kile, M. L. & Navab-Daneshmand, T. Association between heavy metals and antibiotic-resistant human pathogens in environmental reservoirs: a review. Front. Environ. Sci. Eng. 13, 46 (2019).","journal-title":"Front. Environ. Sci. Eng."},{"key":"1373_CR114","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10388","volume":"477","author":"VM D\u2019Costa","year":"2011","unstructured":"D\u2019Costa, V. M. et al. Antibiotic resistance is ancient. Nature 477, 457\u2013461 (2011).","journal-title":"Nature"},{"key":"1373_CR115","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.ese.2025.100557","volume":"25","author":"M Sousa","year":"2025","unstructured":"Sousa, M., Machado, I., Sim\u00f5es, L. C. & Sim\u00f5es, M. Biocides as drivers of antibiotic resistance: a critical review of environmental implications and public health risks. Environ. Sci. Ecotechnol. 25, 100557 (2025).","journal-title":"Environ. Sci. Ecotechnol."},{"key":"1373_CR116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209043119","volume":"120","author":"S Pearl Mizrahi","year":"2023","unstructured":"Pearl Mizrahi, S., Goyal, A. & Gore, J. Community interactions drive the evolution of antibiotic tolerance in bacteria. Proc. Natl Acad. Sci. USA 120, e2209043119 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111534","volume":"28","author":"M Bustamante","year":"2025","unstructured":"Bustamante, M. et al. An eco-evolutionary perspective on antimicrobial resistance in the context of One Health. iScience 28, 111534 (2025).","journal-title":"iScience"},{"key":"1373_CR118","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.adk7368","volume":"384","author":"M Noto Guillen","year":"2024","unstructured":"Noto Guillen, M., Li, C., Rosener, B. & Mitchell, A. Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science 384, 93\u2013100 (2024).","journal-title":"Science"},{"key":"1373_CR119","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/DDDT.S106071","volume":"11","author":"FJ Candel","year":"2017","unstructured":"Candel, F. J. & Pe\u00f1uelas, M. Delafloxacin: design, development and potential place in therapy. Drug Des. Dev. Ther. 11, 881 (2017).","journal-title":"Drug Des. Dev. Ther."},{"key":"1373_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106795","volume":"61","author":"JMO de la Rosa","year":"2023","unstructured":"de la Rosa, J. M. O. et al. High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus. Int. J. Antimicrob. Agents 61, 106795 (2023).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1373_CR121","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1093\/cid\/ciz826","volume":"69","author":"T Sato","year":"2019","unstructured":"Sato, T. & Yamawaki, K. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin. Infect. Dis. 69, S538\u2013S543 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1373_CR122","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41429-024-00762-y","volume":"77","author":"R Kriz","year":"2024","unstructured":"Kriz, R. et al. In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol. J. Antibiot. 77, 757\u2013767 (2024).","journal-title":"J. Antibiot."},{"key":"1373_CR123","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41429-022-00538-2","volume":"75","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium. J. Antibiot. 75, 463\u2013471 (2022).","journal-title":"J. Antibiot."},{"key":"1373_CR124","doi-asserted-by":"publisher","first-page":"e01390-22","DOI":"10.1128\/spectrum.01390-22","volume":"10","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. Development of resistance to eravacycline by Klebsiella pneumoniae and collateral sensitivity-guided design of combination therapies. Microbiol. Spectr. 10, e01390-22 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1373_CR125","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/genes8010039","volume":"8","author":"M Schroeder","year":"2017","unstructured":"Schroeder, M. et al. The complex relationship between virulence and antibiotic resistance. Genes 8, 39 (2017).","journal-title":"Genes"},{"key":"1373_CR126","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/infdis\/jiw402","volume":"215","author":"E Geisinger","year":"2017","unstructured":"Geisinger, E. & Isberg, R. R. Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria. J. Infect. Dis. 215, S9\u2013S17 (2017).","journal-title":"J. Infect. Dis."},{"key":"1373_CR127","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.inf.0000239266.20642.26","volume":"25","author":"R Dagan","year":"2006","unstructured":"Dagan, R., Barkai, G., Leibovitz, E., Dreifuss, E. & Greenberg, D. Will reduction of antibiotic use reduce antibiotic resistance?: the pneumococcus paradigm. Pediatr. Infect. Dis. J. 25, 981 (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1373_CR128","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/s41396-023-01509-7","volume":"17","author":"L Ogunlana","year":"2023","unstructured":"Ogunlana, L. et al. Regulatory fine-tuning of mcr-1 increases bacterial fitness and stabilises antibiotic resistance in agricultural settings. ISME J. 17, 2058\u20132069 (2023).","journal-title":"ISME J."},{"key":"1373_CR129","doi-asserted-by":"publisher","first-page":"e00821-19","DOI":"10.1128\/mSystems.00821-19","volume":"5","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Coexistence of antibiotic resistance genes and virulence factors deciphered by large-scale complete genome analysis. mSystems 5, e00821-19 https:\/\/doi.org\/10.1128\/mSystems.00821-19 (2020).","journal-title":"mSystems"},{"key":"1373_CR130","doi-asserted-by":"publisher","unstructured":"Cole, J. N. & Nizet, V. Bacterial evasion of host antimicrobial peptide defenses. In Virulence Mechanisms of Bacterial Pathogens (eds Kudva, I. T. et al.) 413\u2013443 https:\/\/doi.org\/10.1128\/9781555819286.ch15 (Wiley, 2016).","DOI":"10.1128\/9781555819286.ch15"},{"key":"1373_CR131","first-page":"251","volume":"273","author":"GG Perron","year":"2006","unstructured":"Perron, G. G., Zasloff, M. & Bell, G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273, 251\u2013256 (2006).","journal-title":"Proc. Biol. Sci."},{"key":"1373_CR132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu, Y.-Y. et al. Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161\u2013168 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"1373_CR133","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1473-3099(16)00067-0","volume":"16","author":"MR Mulvey","year":"2016","unstructured":"Mulvey, M. R. et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect. Dis. 16, 289\u2013290 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"1373_CR134","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis, A. et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife 10, e65836 (2021).","journal-title":"eLife"},{"key":"1373_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02149-0","volume":"8","author":"Q Yang","year":"2017","unstructured":"Yang, Q. et al. Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms. Nat. Commun. 8, 2054 (2017).","journal-title":"Nat. Commun."},{"key":"1373_CR136","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"K Hm","year":"2007","unstructured":"Hm, K. et al. Crystal structure of the TLR4\u2013MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906\u2013917 (2007).","journal-title":"Cell"},{"key":"1373_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59550-3","volume":"16","author":"Y Fu","year":"2025","unstructured":"Fu, Y. et al. Structural insight into TLR4\/MD-2 activation by synthetic LPS mimetics with distinct binding modes. Nat. Commun. 16, 4164 (2025).","journal-title":"Nat. Commun."},{"key":"1373_CR138","doi-asserted-by":"publisher","first-page":"585146","DOI":"10.3389\/fimmu.2020.585146","volume":"11","author":"A Zamyatina","year":"2020","unstructured":"Zamyatina, A. & Heine, H. Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4\/11 mediated inflammatory pathways. Front. Immunol. 11, 585146 (2020).","journal-title":"Front. Immunol."},{"key":"1373_CR139","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1073\/pnas.1900570116","volume":"116","author":"BE Poulsen","year":"2019","unstructured":"Poulsen, B. E. et al. Defining the core essential genome of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 116, 10072\u201310080 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR140","doi-asserted-by":"publisher","first-page":"e00682-19","DOI":"10.1128\/JB.00682-19","volume":"202","author":"EA Rundell","year":"2020","unstructured":"Rundell, E. A., Commodore, N., Goodman, A. L. & Kazmierczak, B. I. A screen for antibiotic resistance determinants reveals a fitness cost of the flagellum in Pseudomonas aeruginosa. J. Bacteriol. 202, e00682-19 (2020).","journal-title":"J. Bacteriol."},{"key":"1373_CR141","doi-asserted-by":"publisher","first-page":"297ra114","DOI":"10.1126\/scitranslmed.aab1621","volume":"7","author":"D Roux","year":"2015","unstructured":"Roux, D. et al. Fitness cost of antibiotic susceptibility during bacterial infection. Sci. Transl. Med. 7, 297ra114 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1373_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012442","volume":"21","author":"C Ameline","year":"2025","unstructured":"Ameline, C. et al. Evolution of Escherichia coli strains under competent or compromised adaptive immunity. PLoS Pathog. 21, e1012442 (2025). This research investigates the interplay between host immunity and bacterial evolution, finding that immunocompromised states facilitate distinct resistance trajectories compared with immunocompetent hosts.","journal-title":"PLoS Pathog."},{"key":"1373_CR143","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1021\/acsinfecdis.3c00630","volume":"10","author":"CJ Slingerland","year":"2024","unstructured":"Slingerland, C. J. & Martin, N. I. Recent advances in the development of polymyxin antibiotics: 2010\u20132023. ACS Infect. Dis. 10, 1056\u20131079 (2024).","journal-title":"ACS Infect. Dis."},{"key":"1373_CR144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2504781122","volume":"122","author":"J Peek","year":"2025","unstructured":"Peek, J. et al. Environmental resistome-guided development of resistance-tolerant antibiotics. Proc. Natl Acad. Sci. USA 122, e2504781122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1373_CR145","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41429-019-0228-2","volume":"72","author":"SM Hashimi","year":"2019","unstructured":"Hashimi, S. M. Albicidin, a potent DNA gyrase inhibitor with clinical potential. J. Antibiot. 72, 785\u2013792 (2019).","journal-title":"J. Antibiot."},{"key":"1373_CR146","doi-asserted-by":"publisher","first-page":"22172","DOI":"10.1002\/anie.202104874","volume":"60","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Metagenome-guided analogue synthesis yields improved Gram-negative-active albicidin- and cystobactamid-type antibiotics. Angew. Chem. Int. Ed. 60, 22172\u201322177 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1373_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35940-3","volume":"14","author":"L Dewachter","year":"2023","unstructured":"Dewachter, L. et al. Deep mutational scanning of essential bacterial proteins can guide antibiotic development. Nat. Commun. 14, 241 (2023).","journal-title":"Nat. Commun."},{"key":"1373_CR148","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1126\/science.adk8013","volume":"383","author":"KJY Wu","year":"2024","unstructured":"Wu, K. J. Y. et al. An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance. Science 383, 721\u2013726 (2024).","journal-title":"Science"},{"key":"1373_CR149","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64518","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Chowdhury, S., Rodrigues, J. V. & Shakhnovich, E. Development of antibacterial compounds that constrain evolutionary pathways to resistance. eLife 10, e64518 (2021).","journal-title":"eLife"},{"key":"1373_CR150","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acs.accounts.0c00594","volume":"58","author":"P Szymczak","year":"2025","unstructured":"Szymczak, P. et al. AI-driven antimicrobial peptide discovery: mining and generation. Acc. Chem. Res. 58, 1831\u20131846 (2025).","journal-title":"Acc. Chem. Res."},{"key":"1373_CR151","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban, N. Q. et al. Definitions and guidelines for research on antibiotic persistence. Nat. Rev. Microbiol. 17, 441\u2013448 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR152","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","volume":"17","author":"DI Andersson","year":"2019","unstructured":"Andersson, D. I., Nicoloff, H. & Hjort, K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat. Rev. Microbiol. 17, 479\u2013496 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"1373_CR153","first-page":"20172687","volume":"285","author":"G Yu","year":"2018","unstructured":"Yu, G., Baeder, D. Y., Regoes, R. R. & Rolff, J. Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics. Proc. Biol. Sci. 285, 20172687 (2018).","journal-title":"Proc. Biol. Sci."},{"key":"1373_CR154","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1128\/AAC.02058-12","volume":"57","author":"V Hernandez","year":"2013","unstructured":"Hernandez, V. et al. Discovery of a novel class of boron-based antibacterials with activity against Gram-negative bacteria. Antimicrob. Agents Chemother. 57, 1394\u20131403 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1373_CR155","unstructured":"AN2 Therapeutics announces FDA clearance to proceed with 90-patient investigator-initiated trial (IIT) of epetraborole in patients with M. abscessus lung disease. AN2 Therapeutics https:\/\/go.nature.com\/4rUZHby (2026)."},{"key":"1373_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000819","volume":"18","author":"A Nyerges","year":"2020","unstructured":"Nyerges, A. et al. Rational design of balanced dual-targeting antibiotics with limited resistance. PLoS Biol. 18, e3000819 (2020).","journal-title":"PLoS Biol."},{"key":"1373_CR157","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ng.1034","volume":"44","author":"E Toprak","year":"2012","unstructured":"Toprak, E. et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat. Genet. 44, 101\u2013105 (2012).","journal-title":"Nat. Genet."},{"key":"1373_CR158","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1126\/science.1176950","volume":"325","author":"MOA Sommer","year":"2009","unstructured":"Sommer, M. O. A., Dantas, G. & Church, G. M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128\u20131131 (2009).","journal-title":"Science"},{"key":"1373_CR159","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ismej.2008.86","volume":"3","author":"HK Allen","year":"2009","unstructured":"Allen, H. K., Moe, L. A., Rodbumrer, J., Gaarder, A. & Handelsman, J. Functional metagenomics reveals diverse \u03b2-lactamases in a remote Alaskan soil. ISME J. 3, 243\u2013251 (2009).","journal-title":"ISME J."},{"key":"1373_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10008","volume":"6","author":"P-Y Colin","year":"2015","unstructured":"Colin, P.-Y. et al. Ultrahigh-throughput discovery of promiscuous enzymes by picodroplet functional metagenomics. Nat. Commun. 6, 10008 (2015).","journal-title":"Nat. Commun."},{"key":"1373_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29283-8","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Assessment of global health risk of antibiotic resistance genes. Nat. Commun. 13, 1553 (2022). This study, together with ref. 63, establishes a quantitative, omics-based framework to assess the human health risks of environmental resistance genes, distinguishing high-potential threats from the background resistome.","journal-title":"Nat. Commun."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01373-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:27Z","timestamp":1791378147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01373-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":161,"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01373-0","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"10 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors acknowledge that papers authored by scholars from historically excluded groups are systematically under-cited. Every attempt has been made to reference relevant papers in a manner that is equitable in terms of racial, ethnic, gender and geographical representation.","order":2,"name":"Ethics","label":"Citation diversity statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}